Literature DB >> 11255444

Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

A Bozoki1, B Giordani, J L Heidebrink, S Berent, N L Foster.   

Abstract

BACKGROUND: Some elderly individuals exhibit significant memory deficits but do not have dementia because their general intellect is preserved and they have no impairments in everyday activities. These symptoms are often a precursor to Alzheimer disease (AD), but sometimes dementia does not occur, even after many years of observation. There is currently no reliable way to distinguish between these 2 possible outcomes in an individual patient. We hypothesized that clear impairments in at least 1 cognitive domain in addition to memory would help identify those who will progress to AD.
OBJECTIVE: To determine whether nondemented patients with impairments in memory and other domains are more likely than those with memory impairment alone to develop AD. DESIGN AND METHODS: In a retrospective study, we evaluated 48 nondemented, nondepressed patients with clinical and psychometric evidence of memory impairment who were followed up for 2 or more years. Age-adjusted normative criteria were used to identify whether additional impairments were present in language, attention, motor visuospatial function, and verbal fluency at this initial evaluation. The presence or absence of dementia after 2 years and at the most recent neurological evaluation was compared in subjects with normal scores in all 4 of these cognitive areas apart from memory (M-) and those with impairment in 1 or more of these areas (M+). Outcomes were adjusted for age, intelligence at initial evaluation, and years of education.
RESULTS: Of the 48 nondemented patients with memory loss, 17 met M- criteria, leaving 31 in the M+ group. Deficits in block design were the most frequent abnormality other than memory loss. At the 2-year follow-up, 1 M- subject (6%) had progressed to AD, whereas 15 (48%) of the M+ group had progressed to AD (P =.003). At the most recent follow-up (mean +/- SD, 4.0 +/- 2.0 years), 4 (24%) of the M- patients progressed to AD compared with 24 (77%) of the M+ patients (P<.001).
CONCLUSIONS: Among nondemented elderly patients, memory loss alone rarely progresses to dementia in the subsequent 2 years. However, the risk of dementia is significantly increased among patients with clear cognitive impairments beyond memory loss. Further study is needed to determine whether patients with impairments limited to memory loss have a distinctive clinical course or pathophysiology.

Entities:  

Mesh:

Year:  2001        PMID: 11255444     DOI: 10.1001/archneur.58.3.411

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  78 in total

1.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

4.  A new measure of visual location learning and memory: development and psychometric properties for the Brown Location Test (BLT).

Authors:  Franklin C Brown; Robert M Roth; Andrew J Saykin; Gina Beverly-Gibson
Journal:  Clin Neuropsychol       Date:  2007-09       Impact factor: 3.535

5.  Brain event-related potentials: diagnosing early-stage Alzheimer's disease.

Authors:  Robert M Chapman; Geoffrey H Nowlis; John W McCrary; John A Chapman; Tiffany C Sandoval; Maria D Guillily; Margaret N Gardner; Lindsey A Reilly
Journal:  Neurobiol Aging       Date:  2006-01-20       Impact factor: 4.673

6.  Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.

Authors:  Kristen L Sager; Joanne Wuu; Susan E Leurgans; Howard D Rees; Marla Gearing; Elliott J Mufson; Allan I Levey; James J Lah
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

7.  Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery.

Authors:  Jane B Tornatore; Emory Hill; Jo Anne Laboff; Mary E McGann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

8.  Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

Authors:  Montse Alegret; Mercè Boada-Rovira; Georgina Vinyes-Junqué; Sergi Valero; Ana Espinosa; Isabel Hernández; Gemma Modinos; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga
Journal:  J Clin Exp Neuropsychol       Date:  2009-01-14       Impact factor: 2.475

Review 9.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

10.  Naturalistic assessment of everyday functioning in individuals with mild cognitive impairment: the day-out task.

Authors:  Maureen Schmitter-Edgecombe; Courtney McAlister; Alyssa Weakley
Journal:  Neuropsychology       Date:  2012-07-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.